A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis

NCT00750295 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: SBR759
DRUG: SBR759
DRUG: SBR759
DRUG: SBR759
DRUG: SBR759
DRUG: SBR759
DRUG: SBR759

Sponsor

Novartis Pharmaceuticals